Sort
82,697 grants matching “vaccine development”
Development and Production of Anti-Malarial Biologicals
$819,667Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2021 · AI
Immunoprevention and immunosurveillance of human non-viral cancers
$819,666Olivera J Finn · University Of Pittsburgh At Pittsburgh · R35 · FY2018 · CA
Pacific NorthWest Regional Center of Excellence (PNWRCE)
$819,649Jay A Nelson · Oregon Health & Science University · U54 · FY2009 · AI
Biochemical Mechanism of HIV DNA Integration
$819,601Alan N. Engelman · Dana-Farber Cancer Inst · R37 · FY2025 · AI
Understanding Unconventional CD8+ T cell Responses in Protection from HIV
$819,581Jonah B. Sacha · Oregon Health & Science University · R01 · FY2019 · AI
Malaria Pathogenesis in Pregnant Women and Young Children
$819,564Michal Fried · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Liver resident memory for malaria
$819,482Sean C Murphy · University Of Washington · R01 · FY2020 · AI
Mosquito SAMSP1 and SAMSP2 influence the initial stage of Plasmodium infection of mice
$819,466Erol Fikrig · Yale University · R01 · FY2022 · AI
Novel Adjuvant Discovery in Vaccine Therapy
$819,424Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2013 · AI
Mechanisms of Enhanced Neutralizing Antibody Responses to Rhinovirus C
$819,421Yury A Bochkov · University Of Wisconsin-Madison · R01 · FY2020 · AI
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
$819,364Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
ESTABLISHMENT/MAINTENANCE OF BIOMEDICAL RESEARCH COLONY
$819,282University Of Louisiana At Lafayette · U42 · FY2001 · RR
A National NHP Embryo Resource of Human Genetic Disease Models
$819,192Larry S. Sherman · Oregon Health & Science University · R24 · FY2023 · OD
Effectiveness and Safety of Transcatheter Left Atrial Appendage Occlusion vs. Anticoagulation in Older Adults with Atrial Fibrillation and Alzheimer's Disease and Related dementias
$819,184Joshua K Lin · Brigham And Women'S Hospital · R01 · FY2025 · AG
A universal MHC-E-restricted T cell vaccine for HIV
$819,047Jonah B. Sacha · Oregon Health & Science University · R01 · FY2015 · AI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$818,932David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Structure and Dynamics of the SARS-CoV-2 Spike Protein
$818,913Walther H Mothes · Yale University · R01 · FY2025 · AI
Single Chain Complex Vaccines and Protective Immunity
$818,899University Of Md Biotechnology Institute · R01 · FY2005 · AI
AAV-mediated delivery of eCD4-Ig for prevention and treatment of perinatal HIV infection
$818,853Mauricio De Aguiar Martins · University Of Florida · R01 · FY2022 · HD
Animal and Laboratory Core
$818,828Todd M Allen · Massachusetts General Hospital · P01 · FY2017 · AI
Interrogating human anti-staphylococcal antibody responses for S. aureus vaccine insights
$818,825George Y Liu · University Of California, San Diego · R01 · FY2023 · AI
NIDA Clinical Trials Network: Greater New York Node
$818,688John P Rotrosen · New York University School Of Medicine · UG1 · FY2016 · DA
Elucidating the role of TSR glycosylation in Plasmodium parasites
$818,591Kristian Edward Swearingen · Institute For Systems Biology · R01 · FY2024 · AI
Design of native-like SOSIP trimers
$818,558John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2017 · AI
Overcoming humoral rejection after xenotransplantation in sensitized nonhuman primate recipients
$818,532Jean Kwun · Duke University · R01 · FY2023 · AI